The North American oncolytic virus therapy market is estimated to grow at a CAGR of more than 16% during the forecast period. The market growth is attributed to the established research environment for various biotechnologies, the presence of major healthcare providers and growing healthcare investment in the US and Canada. Moreover, a growing number of cancer patients is augmenting the demand for oncolytic virus therapy. T-Vec (talimogene laherparepvec), is a recently approved oncolytic virus drug in the US and Europe. It is the second-generation oncolytic drug armed with GM-CSF to cure cancer.

Request a free sample of our report on North American Oncolytic Virus Therapy Market : https://www.omrglobal.com/request-sample/north-american-oncolytic-virus-therapy-market

Research is undergoing other oncolytic virus drugs to cure cancer patients suffering from brain tumors along with breast, lung, liver and bladder cancer. There are other oncolytic virus drugs being researched which include JX-594 (pexastimogenedevacirepvec) for hepatocellular carcinoma, GM-CSF-expressing adenovirus CG0070 for bladder cancer, and Reolysin (pelareorep), a wild-type variant of reovirus for head and neck cancer.

A full report of North American Oncolytic Virus Therapy Market Is available at : https://www.omrglobal.com/industry-reports/north-american-oncolytic-virus-therapy-market

North American Oncolytic Virus Therapy Market Segmentation

By Product

HSV-Based Oncolytic Virus

Adenoviruses-Based Oncolytic Virus

Vaccinia Virus-Based Oncolytic Virus

Vesicular Stomatitis Virus-Based Oncolytic Virus

Newcastle Disease Virus- Based Oncolytic Virus

Others

By Application

Prostate Cancer

Breast Cancer

Ovarian Cancer

Melanoma

Others

Regional Analysis

US

Canada

Company Profiles

AbbVie, Inc.

Amgen, Inc.

Bristol-Myers Squibb Company

Cold Genesys Inc.

Creative Biolabs Inc.

Cynvec LLC

DNAtrix Inc.

Genelux Corp.

Janssen Biotech Inc.

Merck & Co., Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/north-american-oncolytic-virus-therapy-market

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404